Skip to main content

Table 1 Patient Characteristics

From: Decompressive craniectomy combined with mild hypothermia in patients with large hemispheric infarction: a randomized controlled trial

Variables DC (n = 9) DCSC (n = 14) DCEH (n = 11) P value
Age, years, mean ± SD 63.22 ± 8.66 56.07 ± 11.23 58.18 ± 9.92 0.298
Male, n (%) 8 (88.9) 11 (78.6) 9 (81.8) 0.817
Comorbidity, n (%)
 Hypertension 4 (44.4) 4 (28.6) 3 (27.3) 0.663
 Coronary heart disease 0 0 0  
 Valvular dysfunction 1 (11.1) 2 (14.3) 2 (18.2) 0.905
 Atrial fibrillation 4 (44.4) 5 (35.7) 3 (27.3) 0.726
 Diabetes mellitus 2 (22.2) 1 (7.1) 1 (9.1) 0.519
 Hyperlipidemia 0 1 (7.1) 0 0.479
 Premorbid stroke 2 (22.2) 1 (7.1) 1 (9.1) 0.519
Left hemispheric affected, n (%) 4 (44.4) 5 (35.7) 5 (45.5) 0.863
Infarcted area, n (%)
 2/3 MCA 1 (11.1) 4 (28.6) 5 (45.5) 0.139
 MCA 4 (44.4) 5 (35.7) 6 (54.5)  
  > MCA 4 (44.4) 5 (35.7) 0  
GCS, mean ± SD 8.78 ± 2.73 10.71 ± 2.59 10.55 ± 2.54 0.198
NIHSS, mean ± SD 19.78 ± 2.64 17.64 ± 3.69 18.36 ± 3.01 0.337
APACHE II, mean ± SD 14.00 ± 4.18 10.43 ± 3.72 10.82 ± 4.73 0.163
Transtentorial herniation, n (%) 2 (22.2) 3 (21.4) 2 (18.2) 0.971
Prior T/A/A/D, n (%) 4 (44.4) 7 (50.0) 4 (36.4) 0.792
Interval time to DCa, hour, mean ± SD 23.28 ± 15.60 37.32 ± 12.21 30.05 ± 12.65 0.075
  1. MCA middle cerebral artery, GCS glasgow coma scale, NIHSS National Institute of Health Stroke Scale, APACHE II acute physiology and chronic health evaluation II, T/A/A/D treatment with thrombolysis, antiplatelet, anticoagulant or defibrinogen, DC decompressive craniectomy
  2. aInterval from symptom onset to DC: DC group vs. DCSC group, P = 0.025; DC group vs. DCEH group, P = 0.298; DCSC group vs. DCEH group, P = 0.159